I AM BIO Podcast

The only podcast at the intersection of biotechnology, politics, patients & the planet. 
Latest Episode: 1st Alzheimer’s Prevention Trial: Thwarting the Brain’s Betrayal
I am BIO Podcast
1st Alzheimer’s Prevention Trial: Thwarting the Brain’s Betrayal

The first clinical study dedicated to preventing Alzheimer’s disease is now in its late stages. Armed with this new data, could neuroscientists be closing in on an elusive breakthrough to defeat neurodegeneration?Subscribe on: Apple Podcasts, Google Podcasts, Spotify, or your player of choice.

 

Image
Podcast Host Michelle McMurry-Heath

This is the only podcast at the intersection of biotechnology, politics, patients and the planet. We spotlight next-generation breakthroughs, the people they help, the global problems they solve and politicians with the power to fast-track a better future or mess it all up. Hosted by BIO President & CEO Dr. Michelle McMurry-Heath.

Produced and edited by Eric Kleiman; engineered and mixed by Jess Fenton; assistant produced by Connor McKoy, Theresa Brady, and Cornelia Poku; digital content by Joe Hansen, and Raffi Seyum; marketing by Jane D’Angelo; formerly hosted by Jim Greenwood.

Subscribe to your favorite podcast player
All Episodes
IamBIO-podcast-COVID19
I AM BIO Trailer

The I AM BIO podcast with host Dr. Michelle McMurry-Heath explores the search for biotechnology breakthroughs and our progress in ending the pandemic, helping patients and carrying the mantle for science and sustainability.  Subscribe to/follow the I AM BIO podcast today on Apple Podcasts, Google Podcasts, Spotify or your podcast player of choice.

I am BIO Podcast
Episode 40: 1st Alzheimer’s Prevention Trial: Thwarting the Brain’s Betrayal

The first clinical study dedicated to preventing Alzheimer’s disease is now in its late stages. The participants are 300 members of the same Colombian family with a rare gene mutation that gives them a 100 percent chance of developing Alzheimer’s disease. Armed with this new data, could neuroscientists be closing in on an elusive breakthrough to defeat neurodegeneration?Hosted by Dr. Michelle McMurry-Heath

IamBIO-epd-39
Episode 39: The Greening of Medicine

As the pandemic lays bare the links between human and environmental health, neuroscience leader Biogen lays out the most aggressive fossil fuel elimination plan of any Fortune 500 company while doubling down on efforts to lead on clinical trial diversity and racial equity.Hosted by Dr. Michelle McMurry-Heath

I am BIO Podcast
Episode 38: Bullish

Biotechnology investors have become key-decision makers in everything from when to open up the states to which medicines can turn the tide in this pandemic the quickest. As the BIO Investor Forum kicks off virtually, a biomedical renaissance has Wall Street bullish on biotech’s future.Hosted by Dr. Michelle McMurry-Heath

IamBIO epd.18
Episode 37: Cancer in the COVID Era (Redux)

Overcrowded hospitals during the pandemic can pose treatment challenges for patients with other serious illnesses. As Kite Pharma CEO Christi Shaw says, “Cancer doesn’t stop in a crisis.” Neither do her company’s employees, who go to extraordinary lengths to get personalized CAR-T treatments to patients.Hosted by Jim Greenwood

IamBIO Epd 36
Episode 36: Synbio Changes Everything

The ability to produce COVID vaccines in record time only scratches the surface of what synthetic biology can do. Gingko Bioworks out of Boston is now 3-D printing millions of letters of DNA code and then using CRISPR to insert it into living cells, transforming what’s scientifically possible.Hosted by Dr. Michelle McMurry-Heath

I am BIO Epd 35
Episode 35: The Wrong Year to Skip Your Flu Shot

As millions return to school, campus and work this fall, the 2020 flu season is shaping up to be something of a pandemic pressure test for our nation. Vaccinations, social distancing and mask-wearing will be the key to containing both flu and COVID and saving countless lives.Hosted by Phyllis Arthur

I am BIO Podcast
Episode 34: COVID-19: We Were Warned (Redux)

For years, leaders on the Bipartisan Commission on Biodefense told Congress and the White House that it wasn’t a matter of if, but when, a pandemic would happen. Exploring the panel’s unheeded recommendations can give the United States a blueprint for what to do going forward.Hosted by Jim Greenwood

I am BIO Podcast Epd 33
Episode 33: A Nation Traumatized

The pandemic has unleashed overwhelming levels of fear, isolation, anxiety and loss in our society. As America comes to grips with the severity of our ongoing mental health crisis, telepsychiatry has emerged as a virtual lifeline to help patients access treatment from home.Hosted by Dr. Michelle McMurry-Heath

I am BIO Podcast Epd 32
Episode 32: Respiratory Rescue?

The engine powering Maryland vaccine maker Novavax is a recombinant nanoparticle platform that is impressing vaccinologists as well as government and nonprofit funders. Learn about the innovative biotech generating big buzz in the global covid vaccine race.Hosted by Dr. Michelle McMurry-Heath

I am BIO Podcast Epd 31
Episode 31: Hydroxychloroquine & the Shorting of Science

BIO President and CEO Dr. Michelle McMurry-Heath speaks with autoimmune disease expert and patient advocate Randy Rutta, President and CEO of the American Autoimmune Related Diseases Association (AARDA) about how the pandemic is affecting vulnerable patients—and how policy could help or hurt. Hosted by Dr. Michelle McMurry-Heath

I am BIO Podcast
Episode 30: Clinical Trials and Tribulations

As Moderna breaks the record for speed on starting its final stage of human testing for its covid vaccine, new BIO CEO Dr. Michelle McMurry-Heath tackles the thorny issue of how to best structure the historic Phase 3 clinical trial with the Boston biotech’s Chief Medical Officer.Hosted by Dr. Michelle McMurry-Heath

IamBIO Vaccines are a Virtue
Episode 29: Vaccines are a Virtue (Redux)

As biotech researchers work around the clock on a covid vaccine, anti-vaxxers must be excoriated in the public square. BIO’s head of infectious disease policy Phyllis Arthur administers a vital dose of vaccine education, because none of us is safe until we all are. Hosted by Jim Greenwood

I am BIO Podcast Epd 28
Episode 28: The Other Pandemic: Beating “Nightmare Bugs” (Part 2 of 2)

COVID and antibiotic resistance are proving to be a lethal combination. What are the biopharma industry and Congress doing to keep your loved ones safe from superbugs? Hosted by Jim Greenwood

I am BIO Podcast Epd 27
Episode 27: The Other Pandemic “Bugs Always Win” (Part 1 of 2)

Long before COVID’s arrival, antibiotic-resistance was a quiet global pandemic. Now that secondary bacterial infections are killing so many vulnerable patients in the COVID era, the pressure is growing for policy makers to finally address the antibiotics market failure. Hosted by Jim Greenwood

COVID & Plastics
Episode 26: COVID & the Plastics Problem

Fear and misinformation about how the coronavirus is transmitted has led to dangerous backsliding in society’s efforts to address plastic pollution. But we don’t have to lose this battle to win the COVID war. Hosted by Jim Greenwood

IamBIO-Epd-16-Herd-Immunity
Episode 25: “Herd” Immunity (Redux)

Biotech companies are working feverishly to develop antibody therapies to provide short-term protection against COVID-19. But what if the novel coronavirus mutates and outwits traditional monoclonal antibodies? Well, that’s where the super cows come in.Hosted by Jim Greenwood

IamBIO Essential Workers
Episode 24: COVID’s Essential Work

The physician-wife of Roivant Sciences CEO Vivek Ramaswamy rushed back to the front lines at the pandemic’s peak — less than a month after giving birth to the couple’s first son. Meanwhile, dad cared for their newborn while testing a promising therapeutic.Hosted by Jim Greenwood

IamBIO Podcast Epd. 23
Episode 23: Deep Diving for COVID Cures

By studying our earliest evolutionary ancestors in the ocean, marine biotech researchers are gaining fresh insights about everything from anti-virals to coronavirus nasal swab testing to the inner workings of our adaptive immune systems.Hosted by Jim Greenwood

Vaccine Velocity
Episode 22: Vaccine Velocity

How can global nonprofits like the Center for Epidemic Preparedness Innovations (CEPI) deliver a safe and effective vaccine against the novel coronavirus in just 12 to 18 months when the world record for vaccine approval is four years?Hosted by Jim Greenwood

IamBIO Podcast Iceland
Episode 21: What Can Iceland Tell Us About COVID?

The people of Iceland — a country of 360,000 — eagerly volunteered for genetic research on how the coronavirus affects a homogeneous population. Amgen’s work in the Land of Fire and here at home could deliver answers and antibodies to help mitigate the pandemic threat.Hosted by Jim Greenwood

IamBIO-podcast
Episode 20: Bats Don’t Have Passports

Modernity is plowing new frontiers, bringing us closer to exotic wildlife rich in viruses that our immune systems have not evolved to fight. Preventing future pandemics will require global cooperation, local action and a comprehensive strategy to monitor infectious disease hotspots.Hosted by Jim Greenwood

IamBIO-epd-19
Episode 19: COVID X-FACTOR

The diversity of our adaptive immune system is why people are reacting so differently to the novel coronavirus. No two people present the virus the exact same way to their immune systems. We’ve evolved in this way as humans to ensure no virus can eradicate our species.Hosted by Jim Greenwood

IamBIO epd.18
Episode 18: Cancer in the COVID Era

Overcrowded hospitals during the pandemic can pose treatment challenges for patients with other serious illnesses. As Kite Pharma CEO Christi Shaw says, “Cancer doesn’t stop in a crisis.” Neither do her company’s employees, who go to extraordinary lengths to get personalized CAR-T treatments to patients.Hosted by Jim Greenwood

IamBIO Podcast epd 9
Episode 17: Biotech's Finest Hour (Redux)

As the world waits for biotechnology to deliver COVID-19 treatments and a vaccine, Ambassador Deborah Birx tells BIO’s scientists: “Expectations are high because you’ve delivered for us before and I know that you can deliver for us again.” BIO chairman Jeremy Levin explains how the industry will rise to meet this moment.Hosted by Jim Greenwood

IamBIO-Epd-16-Herd-Immunity
Episode 16: “Herd” Immunity

Biotech companies are working feverishly to develop antibody therapies to provide short-term protection against COVID-19. But what if the novel coronavirus mutates and outwits traditional monoclonal antibodies? Well, that’s where the super cows come in.Hosted by Jim Greenwood

I am BIO Podcast - 12
Episode 15: COVID-19’s True Origins (Redux)

There's a joke among ecological health scientists that if “you don’t believe one person can change the world, try eating an undercooked bat.” However, what EcoHealth Alliance’s Dr. William Karesh reveals about the trend line for animal-to-human viral transmission is no laughing matter.Hosted by Jim Greenwood

IamBIO Podcast Epd.14
Episode 14: Destroying COVID's Genome

Alnylam Pharmaceuticals, which take its name from the center and brightest star in Orion’s Belt, is working on an RNAi therapy to destroy the genome of the novel coronavirus — and with it, its ability to replicate and kill.Hosted by Jim Greenwood

IamBIO Vaccines are a Virtue
Episode 13: Vaccines are a Virtue

As biotech researchers work around the clock on a covid vaccine, ill-informed, anti-science anti-vaxxers must be denounced and excoriated in the public square. BIO’s head of infectious disease policy Phyllis Arthur administers a vital dose of vaccine education, because none of us is safe until we all are.Hosted by Jim Greenwood

I am BIO Podcast - 12
Episode 12: COVID-19’s True Origins

There's a joke among ecological health scientists that if “you don’t believe one person can change the world, try eating an undercooked bat.” However, what EcoHealth Alliance’s Dr. William Karesh reveals about the trend line for animal-to-human viral transmission is no laughing matter.Hosted by Jim Greenwood

I am BIO Podcast
Episode 11: COVID-19: We Were Warned

For years, leaders on the Bipartisan Commission on Biodefense told Congress and the White House that it wasn’t a matter of if, but when, a pandemic would happen. Exploring the panel’s unheeded recommendations can give the United States a blueprint for what to do going forward.Hosted by Jim Greenwood

IamBIO Podcast epd 9
Episode 10: Going Viral

Vir Biotechnology CEO George Scangos is the scientist selected by his peers to lead the biotechnology industry’s efforts to mitigate and ultimately end the pandemic. He explains how and why the novel coronavirus is so contagious and potentially dangerous to millions.Hosted by Jim Greenwood

IamBIO Podcast
Episode 9: Biotech’s Finest Hour

As the world waits for biotechnology to deliver COVID-19 treatments and a vaccine, Ambassador Deborah Brix tells BIO’s scientists: “Expectations are high because you’ve delivered for us before and I know that you can deliver for us again.” BIO chairman Jeremy Levin explains how the industry will rise to meet this moment.Hosted by Jim Greenwood

I AM BIO - Epd 8
Episode 8: The Antibody Test Shortage

Only antibody testing can tell us who has been infected and recovered from coronavirus and when it might be safe to return to work. There’s a massive global shortage of these tests, and a Maryland biotech is racing to bolster the U.S. supply.Hosted by Jim Greenwood

Sickle Cell
Episode 7: Sickle Cell Saviors

Need a dose of inspiration in a time of national tragedy? A remarkable biotech breakthrough from Global Blood Therapeutics offers fresh hope to patients living with sickle-cell disease.Hosted by Jim Greenwood

iambio-podcast-epd-6
Episode 6: COVID-19 Could Generate 1st Computerized Vaccine

Moderna is the first to clinically test a coronavirus vaccine, created in weeks using only the virus’ genetic code. The breakthrough may be just in time as a former CDC director warns that animal viruses spilling over to humans is the new normal.Hosted by Jim Greenwood

Coronavirus
Episode 5: Coronavirus Lung Treatment Could be Ready In Weeks

Regeneron’s rheumatoid arthritis drug shows promise to treat coronavirus-related lung syndrome and stop the inflammation that leads to death. The company also expects to test a preventative antibody shot in June.Hosted by Jim Greenwood

I AM BIO - Trying our Patients
Episode 4: Trying our Patients

As genetic sequencing gives scientists new tools to hone in on medical mysteries, Washington politicians flirt dangerously with policies that would stymie the genomic revolution while giving patients scant pricing relief at the pharmacy counter.Hosted by Jim Greenwood

An Alternative to Flying Dirty
Episode 3: An Alternative to Flying Dirty

While Swedish climate activist Greta Thunberg has kindled a global dialogue about the ravages of climate change and the role of airline emissions, a Colorado biotech is putting forward a jaw-dropping alternative to flight shaming: actual jet fuel with no carbon footprint.Hosted by Jim Greenwood

iambio-podcast-superbuggin
Episode 2: Superbuggin'

Incurable gonorrhea and the deadly hospital superbug C. diff offer a frightening window into the gathering public health menace of antibiotic resistance. If society doesn’t wake up and tackle the problem, we could be headed toward a calamity on the magnitude of climate change.Hosted by Jim Greenwood

iambio-podcast-firstdose
Episode 1: First Dose

One day before 16-year-old Izzy Thorpe-Wall takes her first dose of Vertex’s stunning Cystic Fibrosis breakthrough, Thorpe and her mother, Clare, open up about their emotional journey and one brave girl’s determination to stay healthy long enough to meet this day of her dreams.Hosted by Jim Greenwood